Enovis CORP ENOV
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
4/9
Piotroski F — financial health
-1.51
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $2.2B | -$1.2B | $1.3B | $19.9M | $1.5B |
| 2024 | $2.1B | -$825.5M | $1.2B | -$67.2M | $2.6B |
| 2023 | $1.7B | -$33.3M | $990.8M | $12.8M | $3.4B |
| 2022 | $1.6B | -$13.3M | $869.4M | -$161.3M | $3.4B |
| 2021 | $1.4B | $71.7M | $777.7M | $251.9M | $4.7B |
| 2020 | $1.1B | $42.6M | $603.6M | $187.2M | $3.6B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Engert Oliver | Chief Administrative Officer | 2026-06-15 | Buy | 1,000 | $20.92 |
| Engert Oliver | Chief Administrative Officer | 2026-06-11 | Buy | 200 | $20.99 |
| Engert Oliver | Chief Administrative Officer | 2026-06-11 | Buy | 1,000 | $21.75 |
| Engert Oliver | Chief Administrative Officer | 2026-06-10 | Buy | 1,000 | $23.00 |
| Engert Oliver | Chief Administrative Officer | 2026-06-01 | Buy | 1,000 | $22.22 |
| Shirley Brady | director | 2026-05-19 | Grant | 9,346 | — |
| Bodem Barbara W. | director | 2026-05-19 | Grant | 9,346 | — |
| Okala Philip | director | 2026-05-19 | Grant | 9,346 | — |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.51 (distress)
- Working capital / assets 0.159
- Retained earnings / assets -0.383
- EBIT / assets -0.293
- Equity / liabilities 0.637
Source: SEC EDGAR filings · CIK 0001420800 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.